Hemogenyx Pharmaceuticals PLC - Presentation at the New York Oncology Investor Conference

Author's Avatar
Nov 06, 2019
Article's Main Image

LONDON, UK / ACCESSWIRE / November 6, 2019 / Hemogenyx Pharmaceuticals plc (LSE:HEMO, Financial), the biopharmaceutical group developing new therapies and treatments designed to transform bone marrow transplantation for the treatment of blood diseases, announces that it will be presenting at the New York Oncology Investor Conference being held on November 12 and 13 in New York, New York.